American Brain Tumor Association Names 2012 Joel A. Gingras, Jr. Award Recipient

  • SHARE
  • EmailFacebookTwitter
    Share on Facebook
    Cancel
    Share on MySpace
    Cancel
    Share on Twitter
    A short URL will be added to the end of your Tweet.

    Cancel
    Share on LinkedIn
    Cancel
Printer Friendly

April 1, 2012 - Chicago, Illinois

The American Brain Tumor Association (ABTA) has named Dr. Steven Brem, chief of the division of Neurosurgical Oncology in the Perelman School of Medicine at the University of Pennsylvania, as the recipient of the 2012 Joel A. Gingras, Jr. Award. Dr. Brem is a member of the American Brain Tumor Scientific Advisory Council and a longtime supporter of the ABTA.

 

The Joel A. Gingras, Jr. Award is given annually to an individual, organization or group that through philanthropy, advocacy, discovery or patient care, has had a major impact on the ability of the American Brain Tumor Association to achieve its mission. The award was established in 2010 in honor of the Joel A. Gingras, Jr. Memorial Foundation, which has raised over $1 million for the American Brain Tumor Association.

 

Dr. Brem currently leads the Penn Brain Tumor Center, a multi-disciplinary center which aims to rapidly move from scientific discovery to patient recovery.

“The most important discoveries in the field of brain tumor research are yet to be made,” noted Dr. Brem, “but with the cancer genome project focused on brain tumors and incredible tools available for brain mapping, we are in a unique position at Penn to translate scientific breakthroughs into clinical progress.”

 

Since 1983, Dr. Brem has performed over 3600 brain surgeries, participated in over 100 clinical trials, and researched the discovery and translation to the clinical arena of novel inhibitors of angiogenesis and glioma invasion. He also chaired the National Comprehensive Cancer Network committee that developed national guidelines for the state-of-the-art treatment of a variety of brain tumors.

From 1997 to 2011, Dr. Brem led the Neuro-Oncology Program and was director of the Neuro-Oncology Research Laboratory at the H. Lee Moffitt Cancer Center in Tampa, FL. Additionally, he sat on the Moffitt Clinical Adivsory Committee that helped create the guidelines for that facility’s brain tumor patient education center, which was funded by the ABTA and was the first such center in the nation.

 

“Dr. Brem exemplifies every aspect of the Joel A. Gingras, Jr. Award,” said Elizabeth M. Wilson, president and CEO of the American Brain Tumor Association. “From research to care to philanthropy, his accomplishments and his scope of service—both the ABTA and to those living with brain tumors—are truly the embodiment of this award.”

 

The award was presented on Saturday, March 24, at The Union League of Philadelphia during the annual JAG Fund Gala.

 

 

ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION

Founded in 1973, the American Brain Tumor Association (ABTA) was the first national nonprofit organization dedicated solely to funding brain tumor research. For nearly 40 years, the Chicago-based ABTA has provided critical funding to researchers working toward breakthroughs in brain tumor diagnosis, treatment and care, and is the only national organization providing comprehensive resources that support the complex needs of brain tumor patients and caregivers. To learn more about the ABTA, visit www.abta.org.

 

# # #